Next Generation Buffered Saline Inhalation Solution

Posted in Press Releases | 10.10.13

Punta Gorda, FL – PharmaCaribe’s PulmoSal™ 7% (pH+)™ (sterile sodium chloride inhalation solution 7%, pH 7.4) received FDA Clearance for commercialization on March 13, 2013 and will be available by prescription from Cystic Fibrosis Services, A Walgreens Alliance Pharmacy on December 1, 2013, and from other pharmacies shortly thereafter. PulmoSal™ 7% (pH+)™ is the first and only FDA-cleared buffered formulation of 7% saline solution for inhalation.